(CBSUS) UBS(Lux)Fund Solutions – - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: LU1215461085

Corporate Bonds, US Dollar, Sustainability, ETF

Description: CBSUS UBS(Lux)Fund Solutions –

UBS (Lux) Fund Solutions – Bloomberg MSCI US Liquid Corp Sust UCITS ETF (USD) A-dis (Ticker: CBSUS, Exchange: SW) is an exchange-traded fund (ETF) designed to track the performance of the Bloomberg MSCI US Liquid Corporate Sustainable UCITS USD Index. This index focuses on US corporate bonds with strong liquidity and sustainability criteria. The fund is structured as a UCITS-compliant ETF, adhering to European regulatory standards for investor protection and transparency.

From a technical perspective, CBSUS has shown a stable price trend, with its 20-day SMA (14.66) slightly above its 50-day SMA (14.53) and 200-day SMA (14.50). This indicates a modest upward trajectory in recent trading sessions. The Average True Range (ATR) of 0.07 reflects low volatility, suggesting the funds price movements are relatively stable. The average 20-day trading volume is 86,996 shares, indicating moderate liquidity for an ETF of this type.

Fundamentally, the ETF manages an assets under management (AUM) of $131.07 million, which is a reasonable scale for a corporate bond-focused ETF. This size allows for efficient tracking of the underlying index while maintaining diversification across the US corporate bond market. The funds focus on sustainable corporate bonds aligns with growing investor demand for ESG-compliant fixed-income products.

3-Month Forecast: Based on the current technical and fundamental data, CBSUS is expected to maintain its stable performance. The 20-day SMA crossing above the 50-day SMA suggests potential short-term upside, though the 200-day SMA remains a key resistance level at 14.50. With an ATR of 0.07, price fluctuations are likely to remain minimal, keeping the fund within a narrow range of 14.45 to 14.85. From a fundamental perspective, sustained demand for sustainable fixed-income products and stable US corporate bond yields support a neutral to slightly positive outlook for the fund over the next quarter.

Additional Sources for CBSUS ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CBSUS ETF Overview

Market Cap in USD 118m
Category USD Corporate Bond
TER 0.10%
IPO / Inception 2015-07-23

CBSUS ETF Ratings

Growth Rating -18.6
Fundamental -
Dividend Rating 38.6
Rel. Strength 7.95
Analysts -
Fair Price Momentum 14.48 USD
Fair Price DCF -

CBSUS Dividends

Dividend Yield 12m 5.86%
Yield on Cost 5y 4.98%
Annual Growth 5y -18.41%
Payout Consistency 100.0%
Payout Ratio %

CBSUS Growth Ratios

Growth Correlation 3m 66%
Growth Correlation 12m 44.4%
Growth Correlation 5y -56.7%
CAGR 5y -3.03%
CAGR/Max DD 5y -0.11
Sharpe Ratio 12m 0.40
Alpha 1.89
Beta -0.021
Volatility 6.10%
Current Volume 0.8k
Average Volume 20d 0.1k
What is the price of CBSUS shares?
As of July 07, 2025, the stock is trading at USD 15.05 with a total of 760 shares traded.
Over the past week, the price has changed by +0.13%, over one month by +1.27%, over three months by +1.00% and over the past year by +5.77%.
Is UBS(Lux)Fund Solutions – a good stock to buy?
Neither. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -18.61 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CBSUS is around 14.48 USD . This means that CBSUS is currently overvalued and has a potential downside of -3.79%.
Is CBSUS a buy, sell or hold?
UBS(Lux)Fund Solutions – has no consensus analysts rating.
What are the forecasts for CBSUS share price target?
According to our own proprietary Forecast Model, CBSUS UBS(Lux)Fund Solutions – will be worth about 15.6 in July 2026. The stock is currently trading at 15.05. This means that the stock has a potential upside of +3.92%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 15.6 3.9%